Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
暂无分享，去创建一个
B. Monk | L. Ramondetta | L. Landrum | M. Method | M. Leitao | L. Wenzel | S. Stockman | R. Penson | A. Oaknin | K. Tewari | Helen Q. Huang | H. Long | T. Reid | Helen E. Michael